Population Pharmacokinetic Modelling and Design of a Bayesian Estimator for Therapeutic Drug Monitoring of Tacrolimus in Lung Transplantation
- 1 March 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 51 (3), 175-186
- https://doi.org/10.2165/11594760-000000000-00000
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult lung and heart-lung transplant report—2010The Journal of Heart and Lung Transplantation, 2010
- Time of Drug Administration, CYP3A5 and ABCB1 Genotypes, and Analytical Method Influence Tacrolimus Pharmacokinetics: A Population Pharmacokinetic StudyTherapeutic Drug Monitoring, 2009
- Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and SolutionsThe AAPS Journal, 2009
- Population Pharmacokinetics of Tacrolimus in Whole Blood and Plasma in Asian Liver Transplant PatientsClinical Pharmacokinetics, 2006
- PsN-Toolkit—A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEMComputer Methods and Programs in Biomedicine, 2005
- Tacrolimus Pharmacokinetics and Dose Monitoring After Lung Transplantation for Cystic Fibrosis and Other ConditionsAmerican Journal of Transplantation, 2005
- Pharmacokinetic Study of Tacrolimus in Cystic Fibrosis and Non-Cystic Fibrosis Lung Transplant Patients and Design of Bayesian Estimators Using Limited Sampling StrategiesClinical Pharmacokinetics, 2005
- Population pharmacokinetics of tacrolimus in adult kidney transplant recipientsClinical Pharmacology & Therapeutics, 2002
- Pharmacokinetics of tacrolimus during the early phase after heart transplantationTransplantation Proceedings, 2001
- Clinical Pharmacokinetics of Tacrolimus in Heart Transplant RecipientsTherapeutic Drug Monitoring, 1999